API5 induces cisplatin resistance through FGFR signaling in human cancer cells

Most tumors frequently undergo initial treatment with a chemotherapeutic agent but ultimately develop resistance, which limits the success of chemotherapies. As cisplatin exerts a high therapeutic effect in a variety of cancer types, it is often used in diverse strategies, such as neoadjuvant, adjuv...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Han Sol, Woo, Seon Rang, Song, Kwon-Ho, Cho, Hanbyoul, Chay, Doo Byung, Hong, Soon-Oh, Lee, Hyo-Jung, Oh, Se Jin, Chung, Joon-Yong, Kim, Jae-Hoon, Kim, Tae Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628271/
https://www.ncbi.nlm.nih.gov/pubmed/28883546
http://dx.doi.org/10.1038/emm.2017.130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628271/
https://www.ncbi.nlm.nih.gov/pubmed/28883546
http://dx.doi.org/10.1038/emm.2017.130

Ejemplares similares